Latest Strategy Changes News

Lake Resources has increased its Measured and Indicated lithium resource at the Kachi Project in Argentina to 8.2 million tonnes LCE, revealing higher-grade lithium zones and enhanced recovery technology. This update strengthens the project's economic outlook amid ongoing feasibility and environmental assessments.

MRG Metals has been granted the Linhuane Heavy Mineral Sands licence in Mozambique, revealing promising historical drilling results with high total heavy mineral grades. This licence enhances MRG’s portfolio and sets the stage for potential early development.

Core Lithium has released a comprehensive Restart Study for its Finniss Lithium Project, outlining a transition to fully underground mining that extends the mine life to 20 years while slashing operating costs and boosting production capacity.

EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.

Core Lithium's Restart Study for the Finniss Lithium Operation confirms a 20-year underground mine life with significant cost reductions and enhanced production capacity.

Lumos Diagnostics has secured its largest single US purchase order for its rapid respiratory test FebriDx, signaling growing adoption in American healthcare settings.

Core Lithium has doubled the Grants Ore Reserve by shifting to underground mining, lifting total Finniss Ore Reserves to 10.73 million tonnes at 1.29% lithium oxide. This update supports a robust 10-year mine plan with potential for extended operations.

Aristocrat Leisure Limited reported a robust HY25 with revenue rising 9% to AUD 3 billion and a 6% increase in NPATA, underpinned by strategic acquisitions and operational resilience. The company signals confidence in sustained growth through innovation and market expansion.

Anteris Technologies has submitted its FDA Investigational Device Exemption for the pivotal PARADIGM Trial of its DurAVR heart valve and marked a milestone of 100 patients treated, while expanding manufacturing capacity amid rising R&D costs.

Tamboran Resources has finalized a US$15 million sale of 100,000 acres to Daly Waters Energy, retaining a dominant 1.9 million-acre position in the Beetaloo Basin and setting the stage for its Phase 2 gas development targeting Australia's East Coast market.

Anteris Technologies Global Corp. reported a $21.9 million net loss for Q1 2025, driven by increased R&D spending as it scales manufacturing and prepares pivotal trials for its DurAVR Transcatheter Heart Valve. The company’s recent $80 million IPO proceeds are being deployed to support these efforts and repay debt.

Lindian Resources reports strong progress on its Kangankunde Rare Earths Project in Malawi, securing multiple financing proposals and advancing construction ahead of schedule. The company targets production in 2026 amid growing global demand for critical minerals.